These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Low serum progranulin predicts the presence of mutations: a prospective study. Schofield EC; Halliday GM; Kwok J; Loy C; Double KL; Hodges JR J Alzheimers Dis; 2010; 22(3):981-4. PubMed ID: 20858962 [TBL] [Abstract][Full Text] [Related]
30. Mutations in progranulin gene: clinical, pathological, and ribonucleic acid expression findings. López de Munain A; Alzualde A; Gorostidi A; Otaegui D; Ruiz-Martínez J; Indakoetxea B; Ferrer I; Pérez-Tur J; Sáenz A; Bergareche A; Barandiarán M; Poza JJ; Zabalza R; Ruiz I; Urtasun M; Fernández-Manchola I; Olasagasti B; Espinal JB; Olaskoaga J; Ruibal M; Moreno F; Carrera N; Martí Massó JF Biol Psychiatry; 2008 May; 63(10):946-52. PubMed ID: 17950702 [TBL] [Abstract][Full Text] [Related]
31. Progranulin genetic variability contributes to amyotrophic lateral sclerosis. Sleegers K; Brouwers N; Maurer-Stroh S; van Es MA; Van Damme P; van Vught PW; van der Zee J; Serneels S; De Pooter T; Van den Broeck M; Cruts M; Schymkowitz J; De Jonghe P; Rousseau F; van den Berg LH; Robberecht W; Van Broeckhoven C Neurology; 2008 Jul; 71(4):253-9. PubMed ID: 18184915 [TBL] [Abstract][Full Text] [Related]
32. Progranulin peripheral levels as a screening tool for the identification of subjects with progranulin mutations in a Portuguese cohort. Almeida MR; Baldeiras I; Ribeiro MH; Santiago B; Machado C; Massano J; Guimarães J; Resende Oliveira C; Santana I Neurodegener Dis; 2014; 13(4):214-23. PubMed ID: 24022032 [TBL] [Abstract][Full Text] [Related]
33. Progranulin mutations in primary progressive aphasia: the PPA1 and PPA3 families. Mesulam M; Johnson N; Krefft TA; Gass JM; Cannon AD; Adamson JL; Bigio EH; Weintraub S; Dickson DW; Hutton ML; Graff-Radford NR Arch Neurol; 2007 Jan; 64(1):43-7. PubMed ID: 17210807 [TBL] [Abstract][Full Text] [Related]
35. Progranulin variability has no major role in Parkinson disease genetic etiology. Nuytemans K; Pals P; Sleegers K; Engelborghs S; Corsmit E; Peeters K; Pickut B; Mattheijssens M; Cras P; De Deyn PP; Theuns J; Van Broeckhoven C Neurology; 2008 Oct; 71(15):1147-51. PubMed ID: 18838661 [TBL] [Abstract][Full Text] [Related]
36. Clinical features of pathologic subtypes of behavioral--variant frontotemporal dementia. Hu WT; Mandrekar JN; Parisi JE; Knopman DS; Boeve BF; Petersen RC; Hutton M; Dickson DW; Josephs KA Arch Neurol; 2007 Nov; 64(11):1611-6. PubMed ID: 17998443 [TBL] [Abstract][Full Text] [Related]
37. Clinicopathologic correlation in PGRN mutations. Davion S; Johnson N; Weintraub S; Mesulam MM; Engberg A; Mishra M; Baker M; Adamson J; Hutton M; Rademakers R; Bigio EH Neurology; 2007 Sep; 69(11):1113-21. PubMed ID: 17522386 [TBL] [Abstract][Full Text] [Related]
38. Higher than expected progranulin mutation rate in a case series of Italian FTLD patients. Tremolizzo L; Gelosa G; Galbussera A; Isella V; Arosio C; Bertola F; Casati G; Piperno A; Ferrarese C; Appollonio I Alzheimer Dis Assoc Disord; 2009; 23(3):301. PubMed ID: 19730171 [No Abstract] [Full Text] [Related]
39. Frontotemporal dementia or frontotemporal lobar degeneration--overview of a group of proteinopathies. Haberland C Ideggyogy Sz; 2010 Mar; 63(3-4):87-93. PubMed ID: 20405665 [TBL] [Abstract][Full Text] [Related]